Michael joins from College Hill where he has worked since 2007, most recently as associate partner.
Michael has over 15 years; life sciences comms experience, including stints at De Facto Communications and Northbanks Communications.
Michael commented: ‘Life sciences is coming out of hibernation; the London and European markets have seen an increase in life sciences financings over recent months and there is also strong and deep venture financing available for the correct companies.
‘Additionally, the pharma industry is actively dismantling non-essential internal R&D capabilities, leaving the opportunity for the smaller life science businesses, through partnerships, to replace that infrastructure.’
Julian Bosdet, chief executive of Abchurch, said: ‘The strength of Abchurch’s Corporate and B2B practice is important in raising the profile of young, innovative start-ups and spin-outs in bioscience. Many companies we are seeing at the moment are early stage and do not have a requirement for financial PR but through our corporate and B2B offerings we can help them to build a reputation within both the industry and the City, to secure commercial partnerships and financing.
‘Many companies see a benefit to staying private and we are here to ensure they have the right communications strategy to support their growth and business models. Strengthening our team in the sector is an important strategic move for Abchurch and I look forward to working with Adam to drive the practice forward.’